Free Trial
NASDAQ:CV

CapsoVision (CV) Stock Price, News & Analysis

CapsoVision logo
$3.91 +0.04 (+1.03%)
As of 08/1/2025 04:00 PM Eastern

About CapsoVision Stock (NASDAQ:CV)

Key Stats

Today's Range
$3.85
$4.02
50-Day Range
N/A
52-Week Range
$3.49
$5.72
Volume
50,843 shs
Average Volume
124,694 shs
Market Capitalization
$181.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Strong Buy

Company Overview

Receive CV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CapsoVision and its competitors with MarketBeat's FREE daily newsletter.

CV Stock News Headlines

Roth Capital Predicts CapsoVision's Q2 Earnings (NASDAQ:CV)
Is America’s Everything Bubble About to Burst?
On July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushing America’s debt-to-GDP ratio to 175%. Top investors are warning of an epic bubble bursting soon. A free guide reveals how to shield your 401(k), savings, and portfolio before the collapse.
CapsoVision (NASDAQ:CV) Coverage Initiated at Benchmark
Roth Capital Upgrades CapsoVision (NASDAQ:CV) to Strong-Buy
See More Headlines

CV Stock Analysis - Frequently Asked Questions

CapsoVision's stock was trading at $4.57 on January 1st, 2025. Since then, CV stock has decreased by 14.4% and is now trading at $3.91.

CapsoVision (CV) raised $28 million in an initial public offering on Wednesday, July 2nd 2025. The company issued 5,300,000 shares at $5.00-$5.50 per share. The Benchmark Company and Roth Capital Partners served as the underwriters for the IPO.

CapsoVision's quiet period expires on Monday, August 11th. CapsoVision had issued 5,500,000 shares in its IPO on July 2nd. The total size of the offering was $27,500,000 based on an initial share price of $5.00. During the company's quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Shares of CV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical, Medical, And Dental Instruments And Supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CV
CIK
1378325
Web
N/A
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$5.00
Potential Upside/Downside
+40.7%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
46,340,000
Free Float
N/A
Market Cap
$181.19 million
Optionable
N/A
Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:CV) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners